“Shift Toward Multiplex and Point-of-Care Immunoassays”
- A key emerging trend in the North America Immunoassay Reagents and Devices Market is the increasing shift toward multiplex immunoassays and point-of-care (POC) testing, driven by the need for faster, more comprehensive diagnostic solutions in both clinical and decentralized settings.
- Multiplex immunoassays allow simultaneous detection of multiple biomarkers in a single sample, significantly improving diagnostic efficiency, reducing sample volume, and enabling more detailed patient profiling—especially critical in oncology, infectious disease monitoring, and autoimmune diagnostics.
- The demand for rapid, on-site testing is further fueling the adoption of compact, portable POC immunoassay devices, particularly in emergency departments, outpatient clinics, and rural healthcare settings where immediate diagnostic decisions are necessary.
- Manufacturers are responding to this trend by developing user-friendly, cartridge-based immunoassay platforms with minimal sample preparation and built-in quality controls, tailored for use by non-specialist operators.
- For instance, companies like QuidelOrtho and Abbott have expanded their POC product lines to include multiplex immunoassay systems capable of detecting respiratory pathogens, cardiac markers, and inflammation indicators within minutes.
- This transition toward multiplex and POC testing is enhancing diagnostic accessibility, supporting faster clinical decision-making, and aligning with broader healthcare goals focused on early detection, patient convenience, and decentralized care delivery.
